Terbinafine
5 NDCs across 3 manufacturers|5 Generic,0 Brand
Terbinafine is used to treat chronic mucocutaneous candidiasis, onychomycosis, tinea capitis, tinea pedis and tinea versicolor, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Apr 29, 1998.
Terbinafine is available as 5 NDCs from 3 manufacturers (5 generic, 0 brand), with NADAC prices from $0.14 to $0.18 per EA — a 30% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
5
5G / 0B
Manufacturers
3
competing in market
Price Spread
$0.14 – $0.18
per EA
7d Activity
avg +2.4% WoW · of 5 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
3 manufacturers producing TERBINAFINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TERBINAFINE HCL 250 MG TABLET | $0.1761 per EA | — |
TERBINAFINE HCL 250 MG TABLET | $0.1356 per EA | +2.39% |
TERBINAFINE HCL 250 MG TABLET | $0.1356 per EA | +2.39% |
TERBINAFINE HCL 250 MG TABLET | $0.1356 per EA | +2.39% |
TERBINAFINE HCL 250 MG TABLET | $0.1356 per EA | +2.39% |
Frequently Asked Questions
What is Terbinafine used to treat?
Terbinafine is used to treat chronic mucocutaneous candidiasis, onychomycosis, tinea capitis, tinea pedis and tinea versicolor, per the National Library of Medicine's MED-RT classification.
How many Terbinafine products are on the market?
The Terbinafine drug market contains 5 NDCs from 3 manufacturers — 5 generic and 0 brand products.
What is the price range for Terbinafine?
NADAC reference prices for Terbinafine range from $0.1356 to $0.1761 per EA — a 30% difference between cheapest and most expensive.
Which manufacturers make Terbinafine?
3 manufacturers list Terbinafine in NADAC. Ranked by number of NDCs, the largest are Chartwell RX LLC (2), Cipla USA Inc. (2), Exelan Pharmaceuticals Inc. (1).
How has the price of Terbinafine changed recently?
Over the past 7 days, 4 Terbinafine NDCs rose and 0 fell, with a market-wide average change of +2.4%.